Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

Bionomics (NASDAQ: BNOX) up 139% - Good PTSD results in an odd stock situation

Bionomics hsa been slightly odd as a stock these past few weeks. Fun and interesting that the treatment seems to work

Update : 28 Sep 2023, 05:49 PM

Bionomics (NASDAQ: BNOX) stock is up 139% today. BNOX stock is up on the news that teh PTSD treatment they’re trying to develop has good Phase II results. For those who don’t quite grasp development pharma that means - roughly - that the treatment actually does something for those with the problem. Phase I is doesn’t poison people. Phase III is few side effects, Phase II’s question is  “Well, does it work?”

The answer seems to be yes: “Bionomics Limited (BNOX) reported positive topline results from Phase 2b ATTUNE trial of BNC210 for the treatment of Post-Traumatic Stress Disorder. The company said the trial met primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.” Which is good, obviously. 

We’d also suggest that a stock issue to raise capital is fairly likely right about now. No development pharma company ever is funded right through the whole testing process. Each point of success increases the value of the company, of course, but that then also gives the opportunity to raise more capital to try to achieve the next part of the process. So, we’d guess at - not insist upon, but indicate it’s likely - a Bionomics stock issue real soon now.

Bionomics stock price from Google Finance

There’s also been a bit of interest recently in Bionomics stock: “Bionomics (ASX: BNO) (NASDAQ: BNOX) shares are down 41% in Australia. The BNO share price decline is the result of the company's decision to delist in Australia. However,  that Nasdaq quote for Bionomics, BNOX, is unchanged on the news. Of course, this is partly to do with time zones. But if that price gap is maintained then for those willing to do some boring paperwork there's an arbitrage here. An arbitrage is also known as “free money”.” That 41% on hte delisting wsa a bit excessive. As it turned out for BNOX: “There could be people moving that Australian stock to the US then selling (the Oz quote has now gone). Which means an artificial wave of selling. That, in turn, might mean that when it’s over there will be a recovery in the stock price. Not exactly an obvious trade we agree but it is possible that the Bionomics stock price weakness is just an artefact of the loss of that Australian quote.”

We do think there’s an amusement to the positive results coming in just after dropping that Australian quote. But, well, that’s the way things work out sometimes. 

Top Brokers